SCHEMBL8128658

SCHEMBL8128658

CCc1nc(-c2ccc(OC)nc2OC)cn1C(CC)C1CC1

nearest known ligand 0.48

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 1/20 0.41
BRD9 Q9H8M2 1/20 0.35
BRD7 Q9NPI1 1/20 0.35
PDE10A Q9Y233 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7133264 0.78 CRHR1 (0.41) CRHR1
SCHEMBL8145013 0.78 CRHR1 (0.39) CRHR1BRD9BRD7PDE10A
SCHEMBL8140649 0.77
SCHEMBL8148384 0.75 CRHR1 (0.46) CRHR1
SCHEMBL7038184 0.74
SCHEMBL8152498 0.73
SCHEMBL7035788 0.73
SCHEMBL7133605 0.72 CRHR1 (0.40) CRHR1
SCHEMBL8146323 0.71 CRHR1 (0.38) CRHR1
SCHEMBL8145397 0.69 CRHR1 (0.39) CRHR1PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0994877-A1 IMIDAZOPYRIMIDINES AND IMIDAZOPYRIDINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS Du Pont Pharmaceuticals Company (US) 2000-04-26 EP disclosed
WO-1999001454-A1 IMIDAZOPYRIMIDINES AND IMIDAZOPYRIDINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS DU PONT PHARMACEUTICALS COMPANY (US) 1999-01-14 WO disclosed